Bio-path Holdings, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OTC.Pink
Director Aline Sherwood acquired options to purchase 2,000 shares of Bio-Path Holdings stock at $1.55 per share.
OTC.Pink
Director Paul Aubert acquired options to purchase 2,000 shares of Bio-Path Holdings stock on July 30, 2024.
OTC.Pink
Heath Cleaver, a director at Bio-Path Holdings, acquired options to purchase 2,000 shares of common stock at $1.55 per share on July 30, 2024.
OTC.Pink
Director Douglas P. Morris acquired options to purchase 3,537 shares of Bio-Path Holdings common stock on July 30, 2024.
OTC.Pink
Peter Nielsen, President, CEO, and CFO of Bio-Path Holdings, Inc., reports the acquisition of options to purchase 25,000 shares of common stock.